← Eichor
Study identifier: NCT07626879 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility and Effectiveness of a Ring-Type Blood Pressure Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring in HFrEF

Condition: Heart Failure With Reduced Ejection Fraction; Hypertension  ·  Sponsor: Keimyung University Dongsan Medical Center

PhaseN/A
Planned participants100
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the feasibility and diagnostic accuracy of the CART-BP ring-type wearable blood pressure monitoring device in comparison with 24-hour ambulatory blood pressure monitoring (ABPM) in patients with heart failure with reduced ejection fraction (HFrEF, LVEF ≤ 40%). As a multi-center, prospective, exploratory study, 100 patients will be enrolled at two tertiary hospitals in South Korea. The agreement between the two devices in 24-hour mean, daytime, and nighttime blood pressure measurements will be assessed per ISO 81060-2:2018 criteria.

This description comes directly from the study's public registry record.

Talk to the study team

In-Cheol Kim  ·  82-53-258-4629  ·  kimic@dsmc.or.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Keimyung University Dongsan Medical CenterDaegu, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07626879